ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 33 filers reported holding ENOCHIAN BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $82,234 | +4111600.0% | 18,397 | +613133.3% | 0.00% | – |
Q2 2023 | $2 | -99.7% | 3 | -99.6% | 0.00% | – |
Q1 2023 | $692 | -64.7% | 756 | -60.3% | 0.00% | – |
Q4 2022 | $1,959 | +95.9% | 1,902 | +534.0% | 0.00% | – |
Q3 2022 | $1,000 | -98.2% | 300 | -99.0% | 0.00% | – |
Q2 2022 | $55,000 | -77.6% | 28,736 | -3.8% | 0.00% | – |
Q1 2022 | $246,000 | +241.7% | 29,871 | +202.3% | 0.00% | – |
Q4 2021 | $72,000 | +1340.0% | 9,880 | +1128.9% | 0.00% | – |
Q3 2021 | $5,000 | – | 804 | +1417.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 53 | -94.2% | 0.00% | – |
Q1 2021 | $3,000 | -62.5% | 915 | -65.9% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 2,685 | +284.1% | 0.00% | – |
Q3 2020 | $2,000 | -75.0% | 699 | -62.6% | 0.00% | – |
Q2 2020 | $8,000 | -33.3% | 1,867 | -53.3% | 0.00% | – |
Q1 2020 | $12,000 | -14.3% | 4,000 | +41.4% | 0.00% | – |
Q4 2019 | $14,000 | +1300.0% | 2,828 | +1516.0% | 0.00% | – |
Q3 2019 | $1,000 | -80.0% | 175 | -83.5% | 0.00% | – |
Q2 2019 | $5,000 | -95.4% | 1,063 | -93.1% | 0.00% | – |
Q1 2019 | $108,000 | – | 15,499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
Ergoteles LLC | 47,984 | $238,000 | 0.01% |
Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
UBS Group AG | 260 | $1,000 | 0.00% |